ClinConnect ClinConnect Logo
Search / Trial NCT05966038

ALS/MND Natural History Study Data Repository

Launched by MASSACHUSETTS GENERAL HOSPITAL · Jul 20, 2023

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

The ALS/MND Natural History Study Data Repository is a research project aimed at better understanding ALS (Amyotrophic Lateral Sclerosis) and other motor neuron diseases like Progressive Muscular Atrophy and Kennedy Disease. This study collects important information from patients who visit participating clinics, including their medical history, symptoms, and family background. By gathering this data, researchers hope to learn more about how these diseases progress over time. The information is collected using a secure platform called NeuroBANK, and personal details are removed to protect participants' privacy before sharing the data with other researchers.

If you or a loved one has been diagnosed with ALS or any other motor neuron disorder and is between the ages of 65 and 87, you may be eligible to participate in this study. Participation involves attending clinic visits where healthcare providers will gather information about your condition. By joining this study, you contribute to valuable research that may help improve the understanding and treatment of these challenging diseases. Participation is voluntary, and your involvement could make a difference for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A clinical diagnosis of El Escorial of suspected, possible, probable, or definite ALS or
  • Other motor neuron disorders, including but not limited to Spinal-Bulbar Muscular Atrophy (SBMA, Kennedy's disease), Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis (PLS), Progressive Muscular Atrophy (PMA), and Progressive Bulbar Palsy (PBP)
  • Exclusion Criteria:
  • Disease does not meet criteria for any motor neuron disorder

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Chicago, Illinois, United States

Minneapolis, Minnesota, United States

Burlington, Massachusetts, United States

Detroit, Michigan, United States

Saint Louis, Missouri, United States

Gainesville, Florida, United States

Tel Aviv, , Israel

Richmond, Virginia, United States

Portland, Oregon, United States

Jerusalem, , Israel

Philadelphia, Pennsylvania, United States

Richmond, Virginia, United States

Milan, , Italy

Pittsburgh, Pennsylvania, United States

Milano, , Italy

Patients applied

0 patients applied

Trial Officials

Alexander Sherman

Principal Investigator

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported